HomeCompareFSKR vs MRK

FSKR vs MRK: Dividend Comparison 2026

FSKR yields 10.20% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FSKR wins by $498951.74M in total portfolio value
10 years
FSKR
FSKR
● Live price
10.20%
Share price
$21.56
Annual div
$2.20
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$498951.80M
Annual income
$489,731,981,317.81
Full FSKR calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — FSKR vs MRK

📍 FSKR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFSKRMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FSKR + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FSKR pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FSKR
Annual income on $10K today (after 15% tax)
$867.35/yr
After 10yr DRIP, annual income (after tax)
$416,272,184,120.14/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, FSKR beats the other by $416,272,175,791.73/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FSKR + MRK for your $10,000?

FSKR: 50%MRK: 50%
100% MRK50/50100% FSKR
Portfolio after 10yr
$249475.93M
Annual income
$244,865,995,557.97/yr
Blended yield
98.15%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

FSKR
Analyst Ratings
1
Buy
1
Hold
1
Sell
Consensus: Buy
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FSKR buys
0
MRK buys
0
No recent congressional trades found for FSKR or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFSKRMRK
Forward yield10.20%2.76%
Annual dividend / share$2.20$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$498951.80M$56.8K
Annual income after 10y$489,731,981,317.81$9,798.13
Total dividends collected$498328.21M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: FSKR vs MRK ($10,000, DRIP)

YearFSKR PortfolioFSKR Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,741$2,040.82$11,206$366.19+$1.5KFSKR
2$18,493$4,860.12$12,650$502.35+$5.8KFSKR
3$32,973$13,185.57$14,407$694.19+$18.6KFSKR
4$79,225$43,943.97$16,585$967.82+$62.6KFSKR
5$282,127$197,356.16$19,342$1,363.89+$262.8KFSKR
6$1,615,525$1,313,649.22$22,913$1,947.19+$1.59MFSKR
7$15,788,922$14,060,309.92$27,662$2,823.89+$15.76MFSKR
8$273,744,350$256,850,203.43$34,159$4,173.35+$273.71MFSKR
9$8,616,652,610$8,323,746,155.53$43,337$6,308.80+$8616.61MFSKR
10$498,951,799,610$489,731,981,317.81$56,776$9,798.13+$498951.74MFSKR

FSKR vs MRK: Complete Analysis 2026

FSKRStock

FS KKR Capital Corp. II, formerly known as FS Investment Corp II, is a business development company specializing in investments in floating rate, senior secured loans-first lien and second line, senior secured bonds, subordinated debt, collateralized securities, corporate bonds, debt securities, equity such as warrants or options in middle market private companies. The fund does not intend to invest to any significant degree in start-up companies, turnaround situations or companies with speculative business plans. It seeks to invest in various sectors such as consumer services, energy, capital goods, software and services, telecommunication services, consumer durables and apparel, diversified financials, materials, automobiles and components, commercial and professional services, media, technology hardware and equipment, health care equipment and services, insurance, retailing, transportation, pharmaceuticals, biotechnology, and life sciences, food and staples retailing, food, beverage, and tobacco, household and personal products, real estate, and utilities. The fund seeks to invest in private companies based in the United States. It also invests in non-U.S. securities, which may include securities denominated in U.S. dollars or in non-U.S. currencies, to the extent permitted by the 1940 Act. The fund purchase interests in loans through secondary market transactions in the ?over-the-counter? market for institutional loans or directly from our target companies. It also purchase minority interests in the form of common or preferred equity in target companies, either in conjunction with one of its debt investments or through a co-investment with a financial sponsor, such as an institutional investor or private equity firm. It may have board representation or board observation rights in its portfolio companies.

Full FSKR Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this FSKR vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FSKR vs SCHDFSKR vs JEPIFSKR vs OFSKR vs KOFSKR vs MAINFSKR vs JNJFSKR vs ABBVFSKR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.